已收盘 02-06 16:00:00 美东时间
-0.150
-0.78%
Sabra Health Care REIT Inc. published an update to their financial calendar Sabra Health Care REIT, Inc. will release its fourth quarter 2025 earnings results on February 12, 2026, after the close of trading. The results will be available on the company’s website at www.sabrahealth.com . A conferenc
02-03 05:06
今日重点评级关注:HC Wainwright & Co.:维持Soleno Therapeutics"买入"评级,目标价从110美元升至120美元;富国银行:维持Soleno Therapeutics"超配"评级,目标价从106美元升至114美元
01-21 11:42
Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Hold and raises the price target from $20 to $21.
01-20 21:08
The latest update is out from Sabra Healthcare REIT ( ($SBRA) ). Sabra Health C...
01-05 22:51
Healthcare REITs saw outsize performance this year compared to the sideways move of the overall sector. The top 10 year to date: Diversified Healthcare Trust (DHC) - Quant Rating: Hold (2.79) | YTD Pe...
2025-12-31 02:26
BofA analysts highlighted a list of companies that historically have benefited from the Federal Reserve’s interest rate cutting cycles since 1989. These are Russell 2000 (IWM) stocks that rank highly ...
2025-12-20 05:24
On CNBC's "Halftime Report Final Trades," experts take a look at Sabra Health Care, Apollo Global Management, Spotify and more.
2025-12-11 20:58
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
2025-11-26 10:07
Wells Fargo analyst John Kilichowski maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overweight and raises the price target from $20 to $21.
2025-11-26 01:04
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
2025-11-19 11:01